AngioDynamics, Inc. Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination
AngioDynamics, Inc. (ANGO) reported Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination of $400.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Notes
us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination · last filed 2026-07-14
- AngioDynamics, Inc. contract with customer, liability, increase (decrease) for contract acquired in business combination for the quarter ending 2023-05-31 was $100.00K, a 83.33% decline year-over-year.
- AngioDynamics, Inc. contract with customer, liability, increase (decrease) for contract acquired in business combination for the quarter ending 2023-02-28 was $100.00K, a 87.50% decline year-over-year.
- AngioDynamics, Inc. contract with customer, liability, increase (decrease) for contract acquired in business combination for the quarter ending 2022-11-30 was $200.00K, a 50.00% decline year-over-year.
- AngioDynamics, Inc. contract with customer, liability, increase (decrease) for contract acquired in business combination for the quarter ending 2022-08-31 was $300.00K, a 25.00% decline year-over-year.
- AngioDynamics, Inc. contract with customer, liability, increase (decrease) for contract acquired in business combination for fiscal 2026 was $400.00K, a 100.00% increase from fiscal 2025.
- AngioDynamics, Inc. contract with customer, liability, increase (decrease) for contract acquired in business combination for fiscal 2025 was $200.00K, a 66.67% decline from fiscal 2024.
- AngioDynamics, Inc. contract with customer, liability, increase (decrease) for contract acquired in business combination for fiscal 2024 was $600.00K, a 14.29% decline from fiscal 2023.
- AngioDynamics, Inc. contract with customer, liability, increase (decrease) for contract acquired in business combination for fiscal 2023 was $700.00K, a 68.18% decline from fiscal 2022.
| Period end | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination 3 month | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination 6 month | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination 9 month | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination 12 month |
|---|---|---|---|---|
| 2026-05-31 | $400.00K 10-K · filed 2026-07-14 | |||
| 2025-05-31 | $200.00K 10-K · filed 2026-07-14 | |||
| 2024-05-31 | $600.00K 10-K · filed 2025-07-18 | |||
| 2023-05-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-25 | $200.00K derived: sum of 2 quarters · filed 2024-07-25 | $400.00K derived: sum of 3 quarters · filed 2024-07-25 | $700.00K 10-K · filed 2024-07-25 |
| 2023-02-28 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-31 | $300.00K derived: sum of 2 quarters · filed 2023-03-31 | $600.00K 10-Q · filed 2023-03-31 | $1.20M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-11-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-06 | $500.00K 10-Q · filed 2023-01-06 | $1.10M derived: sum of 3 quarters · filed 2023-08-03 | $1.90M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-08-31 | $300.00K 10-Q · filed 2022-10-11 | $900.00K derived: sum of 2 quarters · filed 2023-08-03 | $1.70M derived: sum of 3 quarters · filed 2023-08-03 | $2.10M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-05-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-03 | $1.40M derived: sum of 2 quarters · filed 2023-08-03 | $1.80M derived: sum of 3 quarters · filed 2023-08-03 | $2.20M 10-K · filed 2023-08-03 |
| 2022-02-28 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-07 | $1.20M derived: sum of 2 quarters · filed 2022-04-07 | $1.60M 10-Q · filed 2022-04-07 | $1.60M derived: sum of 4 quarters · filed 2022-07-22 |
| 2021-11-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-07 | $800.00K 10-Q · filed 2022-01-07 | $800.00K derived: sum of 3 quarters · filed 2022-07-22 | $1.20M derived: sum of 4 quarters · filed 2022-07-22 |
| 2021-08-31 | $400.00K 10-Q · filed 2021-09-30 | $400.00K derived: sum of 2 quarters · filed 2022-07-22 | $800.00K derived: sum of 3 quarters · filed 2022-07-22 | $1.00M derived: sum of 4 quarters · filed 2022-07-22 |
| 2021-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22 | $400.00K derived: sum of 2 quarters · filed 2022-07-22 | $600.00K derived: sum of 3 quarters · filed 2022-07-22 | $1.00M 10-K · filed 2022-07-22 |
| 2021-02-28 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-31 | $600.00K derived: sum of 2 quarters · filed 2021-03-31 | $1.00M 10-Q · filed 2021-03-31 | $1.50M derived: sum of 4 quarters · filed 2021-07-27 |
| 2020-11-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-08 | $600.00K 10-Q · filed 2021-01-08 | $1.10M derived: sum of 3 quarters · filed 2021-07-27 | $2.40M derived: sum of 4 quarters · filed 2021-07-27 |
| 2020-08-31 | $400.00K 10-Q · filed 2020-10-07 | $900.00K derived: sum of 2 quarters · filed 2021-07-27 | $2.20M derived: sum of 3 quarters · filed 2021-07-27 | $2.40M derived: sum of 4 quarters · filed 2021-07-27 |
| 2020-05-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-27 | $1.80M derived: sum of 2 quarters · filed 2021-07-27 | $2.00M derived: sum of 3 quarters · filed 2021-07-27 | $2.10M 10-K · filed 2021-07-27 |
| 2020-02-29 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-08 | $1.50M derived: sum of 2 quarters · filed 2020-04-08 | $1.60M 10-Q · filed 2020-04-08 | $1.60M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-11-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-08 | $300.00K 10-Q · filed 2020-01-08 | $300.00K derived: sum of 3 quarters · filed 2020-08-10 | $700.00K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-08-31 | $100.00K 10-Q · filed 2019-10-04 | $100.00K derived: sum of 2 quarters · filed 2020-08-10 | $500.00K derived: sum of 3 quarters · filed 2020-08-10 | |
| 2019-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-10 | $400.00K derived: sum of 2 quarters · filed 2020-08-10 | $600.00K 10-K · filed 2020-08-10 | |
| 2019-02-28 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-02 | $600.00K 10-Q · filed 2019-04-02 | ||
| 2018-11-30 | $200.00K 10-Q · filed 2019-01-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |